story of the week
Brigatinib in Patients With NF2-Related Schwannomatosis With Progressive Tumors
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The New England Journal of Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Brigatinib in NF2-Related Schwannomatosis with Progressive Tumors
N. Engl. J. Med 2024 Jun 27;390(24)2284-2294, SR Plotkin, KH Yohay, PL Nghiemphu, CT Dinh, D Babovic-Vuksanovic, VL Merker, A Bakker, G Fell, L Trippa, JO BlakeleyFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Brain Cancer Center of Excellence
Visit our Brain Cancer Center of Excellence for additional, in-depth coverage.